For this purpose, BelVitunifarm uses the latest production equipment, cooperation with research and production institutes and the use of modern achievements in the development and production of medicines allow us to produce about 150 names of veterinary drugs of the highest quality: serums, viral and bacterial vaccines, diagnostics, various chemical and pharmaceutical medicines, more than 100 of which are import-substituting on the territory of the EAEU.
The company has a quality control department that meets the criteria of the Accreditation System of the Republic of Belarus and is accredited for compliance with the requirements of STB ISO/IEC 17025, finished products undergo quality control in its own laboratory.
In addition, the laboratory provides such services to third-party organizations as: determining the authenticity and purity of the active substance, determining the sterility of medicines, determining the concentration of hydrogen ions, testing products for the presence of specific microorganisms, etc.
BelVitunifarm products meet both domestic quality standards and international GMP standards, and are confirmed by numerous positive reviews from consumers of the Republic of Belarus, CIS countries and far abroad.
The foreign economic activity of our company is aimed at achieving growth, development and diversification of exports, increasing export shipments, ensuring their balance and expanding integration processes. Over the past years, we have managed to significantly increase the volume of exports. Thus, a significant geographical coverage was achieved. Today, our export map is quite wide. It includes Russia, Azerbaijan, Kazakhstan, Turkey, Armenia, Uzbekistan, Tajikistan, Turkmenistan, Kyrgyzstan and many other countries. Another important area is Europe. We have established partnership contacts with Polish, Slovenian, and Czech companies. Also, our company is ready to establish contract production, set priorities and ensure mutually beneficial cooperation with manufacturers of veterinary drugs.
JSC "BelVitunifarm", taking into account the needs of customers, performs a full cycle of work on the production of tolled raw materials: packaging, bottling, sublimation, sterilization of veterinary drugs.
Thanks to our flexible pricing policy (promotions, discounts for regular customers, discounts for long-term contracts, large-volume purchases) and numerous offsetting opportunities, we create the best conditions for cooperation in the market of the EAEU member states. Working directly with us as a producer, agricultural organizations save significant money and time.
In the near future, we intend to implement two major innovative projects. The first project on which we are currently focused is related to the construction of a new building of the production site, where the technology for the cultivation of a live attenuated strain of rabies virus will be developed, scaled up, developed and produced vaccine-containing blisters for the "Rabivit VBF anti-rabies vaccine Bait". The project is planned to be implemented by 2025, which corresponds to the priority areas of scientific, technical and innovative activities of JSC BelVitunifarm. The second promising import-substituting project concerns the development of serum production of human blood products. This is a serious step forward for us, as there are no such production facilities in Belarus and Russia yet. The market demand for these drugs is quite large.
Our website: http://belvitunifarm.by/